Published in Hepatitis Weekly, November 19th, 2007
"The method was employed for preparation of > 100 g of P-methylcyclohexyl glycine derivative, 21," wrote A. Arasappan and colleagues.
The researchers concluded: "Incorporation of some of the hindered amino acid derivatives at the P3 position resulted in potent HCV NS3 serine protease inhibitors."
Arasappan and colleagues published their study in Tetrahedron Letters (Practical and efficient method for amino...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.